Clinical Trials

17 enrolled 6 charts

Head and Neck Neoplasms

NCT00256308 2018-05-01

Adjuvant Chemoradiation With Weekly Oxaliplatin in Resected Head and Neck Cancer

6 enrolled 11 charts

Head and Neck Neoplasms

NCT00591149 2017-06-14

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

16 enrolled 5 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT00101075 2017-02-27

Title XELOX FOR SALIVARY GLAND CANCERS

9 enrolled

Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00256295 2017-02-01

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

8 enrolled 7 charts

Head and Neck Neoplasms

NCT00448552 2016-12-15

Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

30 enrolled

CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory

NCT00415298 2014-01-10

AP5346 or Oxaliplatin in Treating Patients With Metastatic and/or Unresectable Recurrent Head and Neck Cancer

Phase NA Unknown

12 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01370876 2013-12-10

Efficacy and Safety Study of Oxaliplatin/5-FU in Patients With Recurrent or Metastatic Head and Neck Cancer

46 enrolled

Head and Neck Neoplasms

NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

35 enrolled

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

NCT00005035 2013-01-31

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00503997 2012-05-10

Pemetrexed and Oxaliplatin in Treating Patients With Locally Advanced Head and Neck Cancer

42 enrolled 7 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT00611754 2008-02-11

Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

15 enrolled